Expression of PRLR was described in a limited cohort (9 patients) of monoblast-like M4 AML patients several decades ago [45] and autocrine/paracrine PRL was associated with survival/proliferation of AML cells [46]. Here, PRL is linked to acute myeloid leukemia.